What QbD Delivers for Pharmaceutical TeamsUntitledA Science-Led Route to Consistent Quality
Quality by Design Training in Zambia introduces Quality by Design (QbD), a systematic, science-based approach to pharmaceutical product and process development in which quality is built into the product from the design stage rather than tested in at the end. Grounded in the ICH Q8(R2), Q9, Q10 and Q11 guidelines, this instructor-led programme moves teams from a test-and-fix habit to genuine process understanding. The course suits formulation and analytical scientists, process development engineers, quality assurance officers and regulatory affairs professionals in Zambia's pharmaceutical, biopharmaceutical and API organisations. You learn to define a Quality Target Product Profile (QTPP), identify Critical Quality Attributes (CQAs), run risk assessments and Design of Experiments (DoE), and set a robust Control Strategy that regulators such as ZAMRA, the FDA and the EMA increasingly expect. As Zambia expands local medicine manufacturing under its national plan, employers need people who can raise processes towards international GMP and QbD standards. Build that capability with Invensis Learning and apply it to live development projects straight away.










